Search for: "Tom Lamb"
Results 541 - 560
of 1,044
Sorted by Relevance
|
Sort by Date
10 Nov 2014, 11:50 am
We will continue to watch for liver failure, drug-induced hepatitis, and liver damage drug injury cases possibly associated with Xarelto blood thinner treatment. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb) Drug Injury Case Evaluation - Free & Confidential (Case review done by attorney Tom… [read post]
20 Jan 2014, 2:12 pm
We will continue to report about testosterone therapy and its increased risk of death, heart attacks, and strokes -- as well as how these "Low T" drugs like Axirom, AndroGel, and Testim became so popular -- in our next article about this emerging drug safety issue. ______________________________________________________________________________ DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects (All website content by attorney Tom Lamb)… [read post]
5 Aug 2021, 1:05 pm
(Case review is done by attorney Tom Lamb) [read post]
22 Mar 2012, 1:15 pm
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. [read post]
16 May 2012, 12:03 pm
Perhaps These Conflicting Findings As Regards Serious NuvaRing Side Effects (PE, DVT, Stroke) Will Prompt FDA To Convene An Advisory Committee Meeting To Consider Safety Of This Vaginal Ring (Posted by Tom Lamb at DrugInjuryWatch.com) Some conflicting and rather disturbing data about the safety of Merck's NuvaRing vaginal ring birth control method emerged in early May 2012 from two different medical studies. [read post]
15 Sep 2009, 11:18 am
Reports About Paxil Cases In Boston, Philadelphia, And Mississippi (Posted by Tom Lamb at DrugInjuryWatch.com) To set the stage we start back in December 2005, when the FDA issued a News Release titled "FDA Advising of Risk of Birth Defects with Paxil", from which we take this excerpt: FDA has asked the manufacturer, Glaxo Smith Kline (GSK), to change the pregnancy category from C to D, a stronger warning. [read post]
Medications Used For Epilepsy And Bipolar Disease Can Increase Risk Of Suicide And Suicidal Ideation
5 Feb 2008, 7:19 am
FDA Will Convene Advisory Committee Meeting To Consider Whether Anti-Epileptic Drugs, Or Perhaps Epilepsy Itself, Associated With Increase In Suicidal Behaviors (Posted by Tom Lamb at DrugInjuryWatch.com) On January 31, 2008 the FDA issued a MedWatch email alert that stated: [T]he Agency has analyzed reports of suicidality (suicidal behavior or ideation) from placebo-controlled clinical studies of eleven drugs used to treat epilepsy as well as psychiatric disorders, and other… [read post]
12 Dec 2007, 2:50 pm
As Of November 2007 J&J Faces 2400 Lawsuits Involving Strokes, Heart Attacks, And Blood Clots Allegedly Caused By Ortho Evra, With Most Cases Pending Before MDL Judge Katz (Posted by Tom Lamb at DrugInjuryWatch.com) In legal motions filed November 20, 2007 by lawyers representing women claiming to have been injured by their use of the Ortho Evra birth control patch, it is asserted that the drug company Johnson & Johnson (J&J) misled the FDA and doctors in… [read post]
19 Oct 2010, 1:24 pm
A Pulmonary Embolism Bellwether Case Will Be Followed By Gallbladder And Venous Thromboembolic Lawsuit Trials (Posted by Tom Lamb at DrugInjuryWatch.com) On October 13, 2010 Judge David Herndon, who is presiding over the federal court YAZ and Yasmin MDL, entered an Order which ended with this statement: Having found that this litigation will benefit from the establishment of bellwether trials, the Court has set firm trial dates and means and method for selecting the cases for… [read post]
30 Jan 2018, 1:00 pm
(Case review done by attorney Tom Lamb) [read post]
4 Feb 2009, 6:36 am
Consider These Five Different Points Of View Presented By The British Medical Journal In Its February 3, 2009 Edition (Posted by Tom Lamb at DrugInjuryWatch.com) On February 4, 2009, the Royal College of Physicians of London (RCP) published a report entitled "Innovating for Health: Patients, Physicians, the Pharmaceutical Industry and the NHS", prepared by a working group chaired by Richard Horton (editor of the Lancet), which… [read post]
14 Mar 2011, 11:12 am
Supreme Court Will Hear Oral Arguments On This Legal Issue In Drug Injury Lawsuit Involving Gladys Mensing (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Justices Hear Arguments in Generic-Drug Lawsuit (3/31/11, New York Times) Transcripts of Oral Arguments to U.S. [read post]
26 Oct 2007, 2:22 pm
One Person Took The Impression That Medtronic Was Trying To Lay Blame For Lead Wire Failures On Those Physicians Who Were Doing The Defibrillator Implants (Posted by Tom Lamb at DrugInjuryWatch.com) To start, our thanks to a fellow in Florida who was kind enough to share with us what he found as a result of some investigation into that hard-to-find March 21, 2007 "Dear Doctor" letter about problems with Medtronic's Sprint Fidelis defibrillator leads. [read post]
29 Mar 2012, 12:10 pm
Mensing, Some Momentum Builds For (Once Again) Allowing Drug Injury Lawsuits On All Prescription Medications, Generic As Well As Brand Name (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Introduction of the “Patient Safety and Generic Labeling Improvement Act” legislation in late April 2012 The Senate bill, S. 2295, was introduced by the Chairman of the Judiciary Committee, Senator… [read post]
23 Jun 2009, 2:44 pm
FDA Has Gone From "No Link" In January 2009 To Wanting An Increased Warning About These Neuropsychiatric Events In June 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) On June 12, 2009 the FDA announced that Singulair (montelukast) as well as some other less popular leukotriene inhibitors -- Accolate (zafirlukast) as well as Zyflo and Zyflo CR (zileuton) -- must start to include a warning on its package insert, or label, regarding an increased… [read post]
21 Feb 2008, 2:56 pm
This January 2008 Rule Issued By FDA Is An Attempt To "End-Run" Congress And Lays The Groundwork For Another Unsafe Drug Debacle Like Vioxx (Posted by Tom Lamb at DrugInjuryWatch.com) On January 16, 2008 the FDA issued a proposed rule whereby a drug company would only have to revise the package insert, or label, for its prescription drugs to add an increased warning about a serious side effect where the drug company, itself, is satisfied there was… [read post]
24 Jan 2008, 2:00 pm
January 2008 Revisions Follow An Avandia Safety Review That Was Completed By EMEA In October 2007 (Posted by Tom Lamb at DrugInjuryWatch.com) On January 24, 2008 GlaxoSmithKline (GSK) announced that the European label for its diabetes drug Avandia (rosiglitazone maleate) will be revised pursuant to a decision by the European Medicines Agency (EMEA)'s Committee for Medicinal Products for Human Use (CHMP). [read post]
10 Jul 2008, 9:40 pm
In July 2008 FDA Said Avelox, With Other Antibiotics In Fluoroquinolone Class, Would Add A "Black-Box" Warning For Tendinitis And Tendon Ruptures (Posted by Tom Lamb at DrugInjuryWatch.com) On July 8, 2008 the FDA announced that a so-called "black-box" warning would be added to the Avelox (moxifloxacin) package insert, or label, to strengthen existing warnings about the increased risk of developing tendinitis and tendon rupture. [read post]
6 May 2008, 8:13 am
Heart Medication Sold By Mylan Was Made In Actavis Plant That Received FDA Letter About Manufacturing Problems Over A Year Ago (Posted by Tom Lamb at DrugInjuryWatch.com) News about the April 2008 Digitek recall came first in the form of a brief company press release dated April 25, which was followed by an FDA MedWatch Safety Alert posted April 28 on the agency's web site. [read post]
4 Jun 2009, 1:34 pm
While Need For Greater Disclosure By FDA Is Evident, Drug Maker Trade Secrets May Be Difficult Obstacle To Overcome (Posted by Tom Lamb at DrugInjuryWatch.com) In early June 2009 it was announced that the FDA would begin to set up a task force within the agency whose purpose is to recommend ways by which there could be more timely disclosure about FDA regulatory and safety decisions. [read post]
